Predictive Implication of Initial Electrocardiogram and Creatine
... Risk factors for coronary artery disease in our patients and studies from western countries are compared in Table 4. The frequency of prior MI and diabetes mellitus were similar in our patients and other studies, but hypertension and smoking were found more frequently in patients from western countr ...
... Risk factors for coronary artery disease in our patients and studies from western countries are compared in Table 4. The frequency of prior MI and diabetes mellitus were similar in our patients and other studies, but hypertension and smoking were found more frequently in patients from western countr ...
1st PRESENTATION
... [8] – Remes J. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991. [9] – Stevenson LW. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989. [10] – Nielsen OW. Retrospective analysis of the cost-effectiveness ...
... [8] – Remes J. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991. [9] – Stevenson LW. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989. [10] – Nielsen OW. Retrospective analysis of the cost-effectiveness ...
Heart development. Heart defects.
... ventricular portion of the cardiac partitions. B – Valves in the atrioventricular orifices under normal conditions. C – Split valves in a persistent atrioventricular canal. D and E – Ostium primum defect caused by incomplete fusion of the atrioventricular endocardial cushions. ...
... ventricular portion of the cardiac partitions. B – Valves in the atrioventricular orifices under normal conditions. C – Split valves in a persistent atrioventricular canal. D and E – Ostium primum defect caused by incomplete fusion of the atrioventricular endocardial cushions. ...
Gross Anatomy of the Heart
... –Hypernatremia-blocks contractions –Hyperkalemia-can cause cardiac arrest; hypo makes cells harder to stimulate ...
... –Hypernatremia-blocks contractions –Hyperkalemia-can cause cardiac arrest; hypo makes cells harder to stimulate ...
SALADIN CHAPTER 19 Cardiovascular System/Heart
... –Hypernatremia-blocks contractions –Hyperkalemia-can cause cardiac arrest; hypo makes cells harder to stimulate ...
... –Hypernatremia-blocks contractions –Hyperkalemia-can cause cardiac arrest; hypo makes cells harder to stimulate ...
“” Investigation of cardiovascular disease “”(Printed by Mostafa Hatim)
... segment analysis. For patients with more infrequent symptoms, small patient-activated ECG recorders can be issued for several weeks until a symptom episode occurs. The patient places the device on the chest to record the rhythm during the episode. With some devices the recording can be transmitted t ...
... segment analysis. For patients with more infrequent symptoms, small patient-activated ECG recorders can be issued for several weeks until a symptom episode occurs. The patient places the device on the chest to record the rhythm during the episode. With some devices the recording can be transmitted t ...
GP guide for the investigation of patients with
... a resting 12-lead ECG to check for arrhythmias, signs of myocardial ischaemia, and evidence of prior myocardial infarction. It should be emphasized that a normal resting ECG is not uncommon even in patients with acute/severe angina and does not exclude the diagnosis of ischaemia. Echo is indicated i ...
... a resting 12-lead ECG to check for arrhythmias, signs of myocardial ischaemia, and evidence of prior myocardial infarction. It should be emphasized that a normal resting ECG is not uncommon even in patients with acute/severe angina and does not exclude the diagnosis of ischaemia. Echo is indicated i ...
The Heart
... b) His heart ejects 75 ml of blood per contraction c) His kidneys produce 320 ml of urine per hour d) All of his wisdom teeth have been removed e) His heart contracts 70 times per minute f) His systolic blood pressure is 130 mmHg g) His diastolic blood pressure is 80 mmHg h) The pressure in his left ...
... b) His heart ejects 75 ml of blood per contraction c) His kidneys produce 320 ml of urine per hour d) All of his wisdom teeth have been removed e) His heart contracts 70 times per minute f) His systolic blood pressure is 130 mmHg g) His diastolic blood pressure is 80 mmHg h) The pressure in his left ...
Long-QT Syndrome
... Long-QT Syndrome (LQTS) is a disorder of the electrical activity of the heart that can result in blackouts (fainting, also known as syncope) or sudden cardiac death. It occurs infrequently and is caused either by an inherited genetic condition (inherited form of LQTS) or by some prescription medicat ...
... Long-QT Syndrome (LQTS) is a disorder of the electrical activity of the heart that can result in blackouts (fainting, also known as syncope) or sudden cardiac death. It occurs infrequently and is caused either by an inherited genetic condition (inherited form of LQTS) or by some prescription medicat ...
ECGS
... An Overview of recent and current research on hormone therapy for treatment of acute conditions: the future? BREAK The Silent Killers: Hypertrophic cardiomyopathy, Congenital Long QT syndrome, Arrhythmogenic Right Ventricular Dysplasia Brugada Syndrome BREAK Case Study Jeopardy: This session will in ...
... An Overview of recent and current research on hormone therapy for treatment of acute conditions: the future? BREAK The Silent Killers: Hypertrophic cardiomyopathy, Congenital Long QT syndrome, Arrhythmogenic Right Ventricular Dysplasia Brugada Syndrome BREAK Case Study Jeopardy: This session will in ...
Two choices for CAD: stents and bypass surgery
... atherosclerosis, the degree of endothelial dysfunction correlates with the patient’s prognosis.” There’s hope that endothelial function could one day become an important screening tool for patients at risk for atherosclerosis. It also could be used to mark a patient’s response to therapy. However, D ...
... atherosclerosis, the degree of endothelial dysfunction correlates with the patient’s prognosis.” There’s hope that endothelial function could one day become an important screening tool for patients at risk for atherosclerosis. It also could be used to mark a patient’s response to therapy. However, D ...
Notes to Heart 2
... output with increases in ventricular enddiastolic volume (pre-load) in the normal heart. Note that with an increase in contractility there is a greater cardiac output for the same ventricular enddiastolic volume. In the diseased heart (C and D), cardiac output is leass and falls if ventricular enddi ...
... output with increases in ventricular enddiastolic volume (pre-load) in the normal heart. Note that with an increase in contractility there is a greater cardiac output for the same ventricular enddiastolic volume. In the diseased heart (C and D), cardiac output is leass and falls if ventricular enddi ...
SHN AMI
... 24-month national Campaign. For re-evaluation March 2007. To help teams develop skills/capacity to monitor their performance and make Quality Improvements (QI) Focus is harm reduction and improving care processes and outcomes for patients ...
... 24-month national Campaign. For re-evaluation March 2007. To help teams develop skills/capacity to monitor their performance and make Quality Improvements (QI) Focus is harm reduction and improving care processes and outcomes for patients ...
Obstructive sleep apnoea in acute coronary syndrome: the invisible
... acute coronary syndrome (ACS) can be unstable angina, non-ST elevation myocardial infarction (NSTEMI) or ST elevation myocardial infarction (STEMI) [1, 3]. Obstructive sleep apnoea (OSA) is a common comorbidity in patients with ACS. There is increasing evidence that sleep disordered breathing is a r ...
... acute coronary syndrome (ACS) can be unstable angina, non-ST elevation myocardial infarction (NSTEMI) or ST elevation myocardial infarction (STEMI) [1, 3]. Obstructive sleep apnoea (OSA) is a common comorbidity in patients with ACS. There is increasing evidence that sleep disordered breathing is a r ...
Long-term ventricular assist devices in current clinical
... 0.002), and the rates at 2 years were 23% and 8% (p = 0.09), respectively” 3. The final conclusion of the trial was that the use of a LVAD in patients with advanced heart failure resulted in a prolonged survival period and an improved quality of life and as such, LVADs may be considered as an accept ...
... 0.002), and the rates at 2 years were 23% and 8% (p = 0.09), respectively” 3. The final conclusion of the trial was that the use of a LVAD in patients with advanced heart failure resulted in a prolonged survival period and an improved quality of life and as such, LVADs may be considered as an accept ...
Press Release
... “Catheter ablation as a method of treating AF is more frequently performed in clinical practice due to its positive effect on AF-related symptoms and quality of life; however, it is associated with a significant thromboembolic risk during and shortly after the procedure,” said Stefan Hohnloser, MD, ...
... “Catheter ablation as a method of treating AF is more frequently performed in clinical practice due to its positive effect on AF-related symptoms and quality of life; however, it is associated with a significant thromboembolic risk during and shortly after the procedure,” said Stefan Hohnloser, MD, ...
Susan F. Saleeb, Wing Yi V. Li, Shira Z. Warren... ; originally published online October 10, 2011;
... normal for 1242 (88.1%). Positive findings potentially related to the complaint of CP were detected in 11 cases (0.8%), including a right coronary artery arising from the left sinus with an interarterial course in 3 cases, pericardial effusion in 5 cases (small: n ⫽ 4; moderate: n ⫽ 1), moderate left ...
... normal for 1242 (88.1%). Positive findings potentially related to the complaint of CP were detected in 11 cases (0.8%), including a right coronary artery arising from the left sinus with an interarterial course in 3 cases, pericardial effusion in 5 cases (small: n ⫽ 4; moderate: n ⫽ 1), moderate left ...
AMI powerpoint from Newfoundland Labrador
... 24-month national Campaign. For re-evaluation March 2007. To help teams develop skills/capacity to monitor their performance and make Quality Improvements (QI) Focus is harm reduction and improving care processes and outcomes for patients ...
... 24-month national Campaign. For re-evaluation March 2007. To help teams develop skills/capacity to monitor their performance and make Quality Improvements (QI) Focus is harm reduction and improving care processes and outcomes for patients ...
Surgical Treatment for Congestive Heart Failure
... Becker C. Injecting some hope. Cell therapy could lead to new treatments for congestive heart failure, whose sufferers now have few options. Mod Healthc [serial on the Internet]. 2003 Aug 11 [cited 2006 Oct 3]; 33(32): [about 3 p.]. Available from: http://web.ebscohost.com/ezproxy.uky.edu/ehost/deli ...
... Becker C. Injecting some hope. Cell therapy could lead to new treatments for congestive heart failure, whose sufferers now have few options. Mod Healthc [serial on the Internet]. 2003 Aug 11 [cited 2006 Oct 3]; 33(32): [about 3 p.]. Available from: http://web.ebscohost.com/ezproxy.uky.edu/ehost/deli ...
Catheter Ablation - Heart Rhythm Society
... be controlled with lifestyle changes or medications. Some patients cannot or do not wish to take life-long antiarrhythmic medications and other drugs because of side effects that interfere with their quality of life. ...
... be controlled with lifestyle changes or medications. Some patients cannot or do not wish to take life-long antiarrhythmic medications and other drugs because of side effects that interfere with their quality of life. ...
RAPID-RF Remote Active Monitoring in Patients
... refer to the Physician’s Desk Reference. Tricuspid valvular disease may be exacerbated by the presence of a lead. Use medical judgment when deciding to place a lead in a patient with triscuspid valvular disease. The lead and its accessories are intended only for one-time use. Do not reuse. Potential ...
... refer to the Physician’s Desk Reference. Tricuspid valvular disease may be exacerbated by the presence of a lead. Use medical judgment when deciding to place a lead in a patient with triscuspid valvular disease. The lead and its accessories are intended only for one-time use. Do not reuse. Potential ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.